AI assistant
SYNTARA LIMITED — Call Transcript 2013
May 22, 2013
65830_rns_2013-05-22_7e381dba-1645-4425-8444-f8b3900d364b.pdf
Call Transcript
Open in viewerOpens in your device viewer
23 May 2013
==> picture [163 x 25] intentionally omitted <==
==> picture [163 x 25] intentionally omitted <==
Media Release
PHARMAXIS INVESTOR CONFERENCE CALL – RESULTS OF BUSINESS REVIEW
Pharmaxis Ltd (PXS) CEO, Mr Gary Phillips will host an investor conference call on Tuesday 28[th] May 2013 at 9.30am (Sydney time) to announce a new business plan following a strategic review of the Company’s business. A media release and presentation will be lodged with the Australian Securities Exchange prior to the call.
Telephone access (toll free): Australia: 1800 059 809 or 1800 606 599
-
USA/Canada: 1855 881 1339
-
UK: 0800 051 8245
-
NZ: 0800 453 055
Telephone access (metered): +61 2 9008 9005
Online access details are available on the Pharmaxis website home page at www.pharmaxis.com.au
A recording of the conference will be available on the Pharmaxis website home page approximately 3 hours after the call.
SOURCE: Pharmaxis Ltd, Sydney, Australia CONTACT: Pharmaxis Investor Relations T: +61 2 9454 7200, F: +61 2 9451 3622, E: [email protected] Website: www.pharmaxis.com.au
Page 1 of 1